Werewolf Therapeutics annual net debt
2020
2021
2022
2023
2024
2025
Werewolf Therapeutics Net Debt Growth & History (HOWL)
Werewolf Therapeutics's net debt was −$15.5M for fiscal 2025.
View full Werewolf Therapeutics company overviewWerewolf Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$15.5M | $52.4M | — |
| 2024 | 2024-12-31 | −$67.9M | $13.8M | — |
| 2023 | 2023-12-31 | −$81.7M | $32.9M | — |
| 2022 | 2022-12-31 | −$114.6M | $27.2M | — |
| 2021 | 2021-12-31 | −$141.9M | −$51.8M | — |
| 2020 | 2020-12-31 | −$90.0M | — | — |
Werewolf Therapeutics quarterly net debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$22.0M | $13.5M | — |
| Q1 2026 | 2026-03-31 | −$5.5M | $44.0M | — |
| Q4 2025 | 2025-12-31 | −$15.5M | $52.4M | — |
| Q3 2025 | 2025-09-30 | −$24.0M | $55.6M | — |
| Q2 2025 | 2025-06-30 | −$35.5M | $56.2M | — |
| Q1 2025 | 2025-03-31 | −$49.5M | $37.8M | — |
| Q4 2024 | 2024-12-31 | −$67.9M | $13.8M | — |
| Q3 2024 | 2024-09-30 | −$79.6M | $37.5M | — |
| Q2 2024 | 2024-06-30 | −$91.7M | $32.1M | — |
| Q1 2024 | 2024-03-31 | −$87.3M | $46.3M | — |
| Q4 2023 | 2023-12-31 | −$81.7M | $32.9M | — |
| Q3 2023 | 2023-09-30 | −$117.1M | $8.2M | — |
| Q2 2023 | 2023-06-30 | −$123.8M | $6.4M | — |
| Q1 2023 | 2023-03-31 | −$133.7M | −$5.7M | — |
| Q4 2022 | 2022-12-31 | −$114.6M | $27.2M | — |
| Q3 2022 | 2022-09-30 | −$125.3M | $43.1M | — |
| Q2 2022 | 2022-06-30 | −$130.2M | $50.9M | — |
| Q1 2022 | 2022-03-31 | −$128.0M | −$45.7M | — |
| Q4 2021 | 2021-12-31 | −$141.9M | −$51.8M | — |
| Q3 2021 | 2021-09-30 | −$168.4M | — | — |
| Q2 2021 | 2021-06-30 | −$181.0M | — | — |
| Q1 2021 | 2021-03-31 | −$82.2M | — | — |
| Q4 2020 | 2020-12-31 | −$90.0M | — | — |
Werewolf Therapeutics net debt trends
Over the last five fiscal years, Werewolf Therapeutics's net debt increased from −$90.0M to −$15.5M, a change of $74.5M. The latest reported quarter, Q2 2026, shows −$22.0M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Werewolf Therapeutics source filings ↗